Global Information
회사소개 | 문의

좌심실보조장치 : 의료기기 파이프라인 평가

Left Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2018

리서치사 GlobalData
발행일 2018년 06월 상품 코드 646073
페이지 정보 영문 130 Pages
가격
US $ 4,000 ₩ 4,515,200 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 9,030,400 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 13,545,600 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


좌심실보조장치 : 의료기기 파이프라인 평가 Left Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2018
발행일: 2018년 06월 페이지 정보 : 영문 130 Pages

한글목차

세계 좌심실보조장치 시장의 주요 파이프라인 제품(의료기기)과 임상시험 진행 상황에 대해 조사했으며, 제품 특성 비교 분석(임상시험 진행 단계별), 주요 기업의 개요 및 대표적 제품, 최근 시장 동향(자본거래·사업 제휴 등) 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 좌심실보조장치의 개요

제3장 현재 임상시험중인 제품

  • 파이프라인 제품 : 임상시험 단계별
  • 파이프라인 제품 : 영역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별
  • 현재 진행중인 임상시험

제4장 좌심실보조장치 : 각 기업에서 현재 임상시험중인 파이프라인 제품

  • 좌심실보조장치 기업 : 임상시험 단계별 파이프라인 제품
  • 좌심실보조장치 : 임상시험 단계별 파이프라인 제품

제5장 좌심실보조장치 기업·제품의 개요

  • Abiomed Inc
  • BioVentrix Inc
  • Calon Cardio-Technology Ltd
  • CARDIAnove
  • Cleveland Clinic Hospital
  • Cleveland Heart Inc
  • CorAssist Cardiovascular Ltd
  • CorWave
  • Duke University
  • Evaheart Inc
  • Everheart Systems, LLC
  • FineHeart
  • HeartWare International Inc
  • Jarvik Heart Inc
  • LaunchPoint Technologies, Inc.
  • Leviticus Cardio Ltd
  • Levram Medical Systems Ltd
  • Medtronic plc
  • Perfusion Solution Inc
  • PlugMed Heart SAS
  • Procyrion
  • ReliantHeart, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Sunshine Heart Company, Pty. Ltd.
  • Teleflex Inc
  • Terumo Corp
  • Thoratec Corp
  • Tokyo Medical and Dental University
  • U.S. Stem Cell Inc
  • Windmill Cardiovascular Systems, Inc.
  • Yale University

제6장 좌심실보조장치 시장 : 최근 동향(총 30건)

제7장 부록

KSA 18.06.12

영문목차

GlobalData's Medical Devices sector report, "Left Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Left Ventricular Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Left Ventricular Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope:

  • Extensive coverage of the Left Ventricular Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Left Ventricular Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy:

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Left Ventricular Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Left Ventricular Assist Devices Overview

3. Products under Development

  • 3.1. Left Ventricular Assist Devices - Pipeline Products by Stage of Development
  • 3.2. Left Ventricular Assist Devices - Pipeline Products by Territory
  • 3.3. Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
  • 3.4. Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
  • 3.5. Left Ventricular Assist Devices - Ongoing Clinical Trials

4. Left Ventricular Assist Devices - Pipeline Products under Development by Companies

  • 4.1. Left Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
  • 4.2. Left Ventricular Assist Devices - Pipeline Products by Stage of Development

5. Left Ventricular Assist Devices Companies and Product Overview

  • 5.1. Abiomed Inc Company Overview
  • 5.2. BioVentrix Inc Company Overview
  • 5.3. Calon Cardio-Technology Ltd Company Overview
  • 5.4. CARDIAnove Company Overview
  • 5.5. Cleveland Clinic Hospital Company Overview
  • 5.6. Cleveland Heart Inc Company Overview
  • 5.7. CorAssist Cardiovascular Ltd Company Overview
  • 5.8. CorWave Company Overview
  • 5.9. Duke University Company Overview
  • 5.10. Evaheart Inc Company Overview
  • 5.11. Everheart Systems, LLC Company Overview
  • 5.12. FineHeart Company Overview
  • 5.13. HeartWare International Inc Company Overview
  • 5.14. Jarvik Heart Inc Company Overview
  • 5.15. LaunchPoint Technologies, Inc. Company Overview
  • 5.16. Leviticus Cardio Ltd Company Overview
  • 5.17. Levram Medical Systems Ltd Company Overview
  • 5.18. Medtronic plc Company Overview
  • 5.19. Perfusion Solution Inc Company Overview
  • 5.20. PlugMed Heart SAS Company Overview
  • 5.21. Procyrion Company Overview
  • 5.22. ReliantHeart, Inc. Company Overview
  • 5.23. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
  • 5.24. Sunshine Heart Company, Pty. Ltd. Company Overview
  • 5.25. Teleflex Inc Company Overview
  • 5.26. Terumo Corp Company Overview
  • 5.27. Thoratec Corp Company Overview
  • 5.28. Tokyo Medical and Dental University Company Overview
  • 5.29. U.S. Stem Cell Inc Company Overview
  • 5.30. Windmill Cardiovascular Systems, Inc. Company Overview
  • 5.31. Yale University Company Overview

6. Left Ventricular Assist Devices- Recent Developments

  • 6.1. May 22, 2018: Abbott Recalls the HeartMate 3 Left Ventricular Assist System Due to Potential Malfunction that may Lead to Graft Occlusion
  • 6.2. May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration
  • 6.3. May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
  • 6.4. May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives
  • 6.5. May 09, 2018: U.S. Stem Cell Reports First Quarter Results
  • 6.6. May 04, 2018: Abbott Implements Corrective Action for HeartMate 3 Heart Pump
  • 6.7. May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year
  • 6.8. May 03, 2018: Teleflex Reports First Quarter 2018 Results
  • 6.9. Apr 30, 2018: Procyrion Appoints Clinical Operations Pro Tara Burt As Associate Director Of Clinical Affairs
  • 6.10. Apr 16, 2018: USRM Reports 2017 Financial Results
  • 6.11. Apr 10, 2018: Leviticus Cardio Confirms the Successful Completion of a Long-term Chronic Animal Study
  • 6.12. Apr 09, 2018: Medtronic to Unveil Additional Clinical Data on HVAD System at ISHLT 2018
  • 6.13. Apr 04, 2018: Abiomed Announces European Approval (CE Marking) for Impella 5.5 and First Patient Treated at University Heart Center Hamburg
  • 6.14. Apr 02, 2018: Abiomed Receives FDA Approval for Impella CP with SmartAssist and Optical Sensor
  • 6.15. Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
  • 6.16. Mar 21, 2018: Procyrion Names Elisabeth Neely Senior Vice President Of Clinical And Regulatory Affairs, Formerly With Abbott
  • 6.17. Mar 14, 2018: Baylor College of Medicine approved for $489,000 in funding for LVAD treatment decision support
  • 6.18. Mar 13, 2018: UR Medicine Leads U.S. in Minimally Invasive Surgery for Newest LVAD Heart Pump
  • 6.19. Mar 11, 2018: New Long-term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's Heartmate 3 Heart Pump
  • 6.20. Mar 01, 2018: Palmetto Health is first facility in state to implant HeartMate 3 LVAD outside of research trials
  • 6.21. Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance
  • 6.22. Feb 14, 2018: Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures
  • 6.23. Feb 13, 2018: Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
  • 6.24. Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery
  • 6.25. Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
  • 6.26. Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy
  • 6.27. Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
  • 6.28. Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
  • 6.29. Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year
  • 6.30. Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Left Ventricular Assist Devices - Pipeline Products by Stage of Development
  • Table 2: Left Ventricular Assist Devices - Pipeline Products by Territory
  • Table 3: Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
  • Table 4: Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
  • Table 5: Left Ventricular Assist Devices - Ongoing Clinical Trials
  • Table 6: Left Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
  • Table 7: Left Ventricular Assist Devices - Pipeline Products by Stage of Development
  • Table 8: Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Impella BTR - Product Status
  • Table 10: Impella BTR - Product Description
  • Table 11: Impella CP (Cardiac Power) - Product Status
  • Table 12: Impella CP (Cardiac Power) - Product Description
  • Table 13: Impella ECP - Product Status
  • Table 14: Impella ECP - Product Description
  • Table 15: Next Generation Impella CP - STEMI - Product Status
  • Table 16: Next Generation Impella CP - STEMI - Product Description
  • Table 17: Abiomed Inc - Ongoing Clinical Trials Overview
  • Table 18: Impella CP (Cardiac Power) - A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry
  • Table 19: Impella CP (Cardiac Power) - Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial
  • Table 20: Impella CP (Cardiac Power) - Pulsecath mechanical Support Evaluation (PULSE) - Trial
  • Table 21: Next Generation Impella CP - STEMI - Door to Unloading with IMPELLA CP System in Acute Myocardial Infarction to Reduce Infarct Size (DTU): A Prospective Feasibility Study
  • Table 22: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: PliCath HF - Product Status
  • Table 24: PliCath HF - Product Description
  • Table 25: BioVentrix Inc - Ongoing Clinical Trials Overview
  • Table 26: PliCath HF - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy
  • Table 27: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Calon MiniVAD - Product Status
  • Table 29: Calon MiniVAD - Product Description
  • Table 30: MicroVAD - Product Status
  • Table 31: MicroVAD - Product Description
  • Table 32: CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: CARDIAnove Pump - Product Status
  • Table 34: CARDIAnove Pump - Product Description
  • Table 35: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: PediPump - Product Status
  • Table 37: PediPump - Product Description
  • Table 38: Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: SmartHeart LVAD - Product Status
  • Table 40: SmartHeart LVAD - Product Description
  • Table 41: CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: CORolla - Product Status
  • Table 43: CORolla - Product Description
  • Table 44: CorAssist Cardiovascular Ltd - Ongoing Clinical Trials Overview
  • Table 45: CORolla - CORolla TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction
  • Table 46: CORolla - CORolla TAA for Heart Failure with Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility
  • Table 47: CorWave Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: CorWave Neptune - Product Status
  • Table 49: CorWave Neptune - Product Description
  • Table 50: CorWave Nemo - Product Status
  • Table 51: CorWave Nemo - Product Description
  • Table 52: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Para-Aortic Blood Pump - Product Status
  • Table 54: Para-Aortic Blood Pump - Product Description
  • Table 55: Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: EVAHEART Left Ventricular Assist System - Product Status
  • Table 57: EVAHEART Left Ventricular Assist System - Product Description
  • Table 58: Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Fully Implantable Left Ventricular Assist Device - Product Status
  • Table 60: Fully Implantable Left Ventricular Assist Device - Product Description
  • Table 61: FineHeart Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: ICOMS - Product Status
  • Table 63: ICOMS - Product Description
  • Table 64: HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Status
  • Table 66: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Description
  • Table 67: Longhorn - Product Status
  • Table 68: Longhorn - Product Description
  • Table 69: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Status
  • Table 70: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Description
  • Table 71: VCAN Trans-Mitral - Product Status
  • Table 72: VCAN Trans-Mitral - Product Description
  • Table 73: HeartWare International Inc - Ongoing Clinical Trials Overview
  • Table 74: Miniaturized Ventricular Assist Device (MVAD) Pump - Multi Center, Prospective, Non-randomized, Single-arm Trial Evaluating the Clinical Safety and Performance of the HeartWare MVAD System for the Treatment of Advanced Heart Failure
  • Table 75: Jarvik Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Jarvik 15mm LVAD System - Product Status
  • Table 77: Jarvik 15mm LVAD System - Product Description
  • Table 78: Jarvik 2000 Heart - Bridge To Transplant - Product Status
  • Table 79: Jarvik 2000 Heart - Bridge To Transplant - Product Description
  • Table 80: Jarvik 2000 Heart - Destination Therapy - Product Status
  • Table 81: Jarvik 2000 Heart - Destination Therapy - Product Description
  • Table 82: Jarvik Heart Inc - Ongoing Clinical Trials Overview
  • Table 83: Jarvik 2000 Heart - Destination Therapy - Evaluation of the Jarvik 2000 Left Ventricular Assist System with Post-auricular Connector--Destination Therapy Study
  • Table 84: LaunchPoint Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Pediaflow Pediatric VAD - Product Status
  • Table 86: Pediaflow Pediatric VAD - Product Description
  • Table 87: Streamliner VAD - Product Status
  • Table 88: Streamliner VAD - Product Description
  • Table 89: Leviticus Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Coplanar Energy Transfer System - Product Status
  • Table 91: Coplanar Energy Transfer System - Product Description
  • Table 92: Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: LEVRAM-Ventricular Assist Device - Product Status
  • Table 94: LEVRAM-Ventricular Assist Device - Product Description
  • Table 95: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 96: HVAD System - Thoracotomy - Product Status
  • Table 97: HVAD System - Thoracotomy - Product Description
  • Table 98: Perfusion Solution Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 99: Transapical LVAD - Product Status
  • Table 100: Transapical LVAD - Product Description
  • Table 101: PlugMed Heart SAS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: Implantable Left Ventricular Assist Device - Product Status
  • Table 103: Implantable Left Ventricular Assist Device - Product Description
  • Table 104: Procyrion Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: Aortix Device - Product Status
  • Table 106: Aortix Device - Product Description
  • Table 107: ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 108: aVAD - Product Status
  • Table 109: aVAD - Product Description
  • Table 110: aVAD Liberty System - Product Status
  • Table 111: aVAD Liberty System - Product Description
  • Table 112: HeartAssist 5 Adult VAD - Product Status
  • Table 113: HeartAssist 5 Adult VAD - Product Description
  • Table 114: ReliantHeart, Inc. - Ongoing Clinical Trials Overview
  • Table 115: HeartAssist 5 Adult VAD - A Prospective, Randomized, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5 VAD System Compared to the Thoratec HeartMate II VAD and HeartWare HVAD for Left Ventricular Support in Patients Awaiting Cardiac Transplantation
  • Table 116: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 117: Paracorporeal Left Ventricle Assist Device - Product Status
  • Table 118: Paracorporeal Left Ventricle Assist Device - Product Description
  • Table 119: Sunshine Heart Company, Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 120: C-Pulse - Wireless Version - Product Status
  • Table 121: C-Pulse - Wireless Version - Product Description
  • Table 122: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 123: CorAide Left Ventricular Assist System - Product Status
  • Table 124: CorAide Left Ventricular Assist System - Product Description
  • Table 125: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 126: DuraHeart Destination Therapy Left Ventricular Assist System - Product Status
  • Table 127: DuraHeart Destination Therapy Left Ventricular Assist System - Product Description
  • Table 128: Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 129: DuraHeart II - Product Status
  • Table 130: DuraHeart II - Product Description
  • Table 131: HeartMate III LVAS - Destination Therapy - Product Status
  • Table 132: HeartMate III LVAS - Destination Therapy - Product Description
  • Table 133: Thoratec Corp - Ongoing Clinical Trials Overview
  • Table 134: HeartMate III LVAS - Destination Therapy - Driveline Silicone Skin Interface (SSI) Registry
  • Table 135: HeartMate III LVAS - Destination Therapy - Heartmate 3 CE Mark Clinical Investigation Plan
  • Table 136: HeartMate III LVAS - Destination Therapy - Hemodynamic Guidance with PA-sensor CardioMEMS in Patients with an Left Ventricular Assist Device (VAD)
  • Table 137: HeartMate III LVAS - Destination Therapy - Momentum 3 Cap Multi-center Study of Maglev Technology in Patients Undergoing MCS Therapy with Heartmate 3 Continued Access Protocol
  • Table 138: Tokyo Medical and Dental University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 139: TinyPump - Product Status
  • Table 140: TinyPump - Product Description
  • Table 141: U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 142: SVAD - Product Status
  • Table 143: SVAD - Product Description
  • Table 144: Windmill Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 145: TORVAD - Product Status
  • Table 146: TORVAD - Product Description
  • Table 147: Yale University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 148: BoLetz Pump - Product Status
  • Table 149: BoLetz Pump - Product Description
  • Table 150: Glossary

List of Figures

  • Figure 1: Left Ventricular Assist Devices - Pipeline Products by Stage of Development
  • Figure 2: Left Ventricular Assist Devices - Pipeline Products by Territory
  • Figure 3: Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
  • Figure 4: Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
  • Figure 5: Left Ventricular Assist Devices - Ongoing Clinical Trials
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research